Business Context and Reporting Period
This Form 8-K filing by ASTROTECH Corp (Delaware) covers the date of February 22, 2018. The report details a material modification to the rights of securities holders regarding the Company's poison pill plan (Rights Agreement).
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is strictly a legal disclosure regarding corporate governance and shareholder rights.
Material Changes
On February 22, 2018, the Company and the Rights Agent entered into Amendment Nine to the Rights Agreement. The material changes include:
- Governing Law: Changed from the State of Washington to the State of Delaware.
- Underlying Security: The preferred stock purchasable upon exercise of the Rights was changed from one-thousandth of a share of Series D Junior Participating Preferred Stock to one-thousandth of a share of Series A Junior Participating Preferred Stock.
Note: The filing references a prior amendment (Amendment Eight) from July 20, 2017, which extended the Expiration Date to August 10, 2018, and increased the Purchase Price to $3.31. Amendment Nine did not alter the expiration date or purchase price.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The primary risk disclosed relates to the modification of the terms under which shareholders may exercise their rights, specifically the change in the class of preferred stock and the governing jurisdiction.
Investor Verification Checklist
- Verify the specific terms of the new Series A Junior Participating Preferred Stock compared to the previous Series D.
- Confirm the implications of the change in governing law from Washington to Delaware on shareholder rights enforcement.
- Review the full text of Amendment Nine (Exhibit 4.1) for any additional clauses not summarized in the 8-K.
- Check the current status of the Rights Agreement expiration date (August 10, 2018) to ensure no further extensions are pending.